RecruitingNCT04084860
Study of glutamate-modulating medicines for alcohol use
About this title
Read the official source — NCT04084860Medication studyAges 21–70United StatesAddiction
Understand this study
Who could participate?
Listed age limits: 21 years to 70 years.
- Listed locations
- New YorkSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: November 8, 2019
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 120
- Sponsor
- New York State Psychiatric Institute
- Sponsor type
- Research institute
- Study type
- Behavioral
- Intervention type
- Behavioural, Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 21 Years to 70 Years
- Official registry ID
- NCT04084860
- Official title
Show the full official title
The Role of Brief Potent Glutamatergic Modulation in Addressing Problem Drinking: a Randomized, Controlled Trial
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
New York
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is New York State Psychiatric Institute, a research institute.
Does this study involve medication?
Yes. The study involves medication, including CI-581a and CI-581b.
Who can participate?
Listed age limits: 21 years to 70 years.
Is this study still recruiting?
The registry lists this study as recruiting.
